Coronavirus Update - 09th November 2020

We would like to reassure our customers that as England enters its second national lockdown period, we remain open for business and at full capacity as we have done since the start of this pandemic and fully comply with all government guidance on minimising the risks of COVID-19.

As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

The latest blogs from Arcinova

August 2, 2020

Industry Insights… with Louise Philips

Welcome to the latest blog in our Industry Insights series, where we ask our experts to share their in-depth expertise on topics within the pharmaceutical industry. In this instalment, we asked ou
July 8, 2020

Industry Insights… with Angela Fuller

Welcome to the latest blog in our Industry Insights series, where we ask our experts to share their in-depth expertise on topics within the pharmaceutical industry. In this instalment, we asked ou
June 23, 2020

Industry Insights… with Graham Exley

Welcome to the latest blog in our Industry Insights series, where we ask our experts to share their in-depth expertise on topics within the pharmaceutical industry. We recently asked our Environme
May 27, 2020

Industry Insights with… David Fleet

Welcome to the latest blog in our Industry Insights series, where we ask our experts to share their in-depth expertise on topics within the pharmaceutical industry. Our Head of Formulation Develop
May 27, 2020

In conversation with… our young bioanalysts

We sat down with Emma Webster, Paige Bellis and Jenny Baker from our bioanalytical team to discuss how they began their careers in drug development and what they enjoy most about their roles. Read
May 26, 2020

Industry Insights with… Rory MacDonald

Welcome to the latest blog in our Industry Insights series, where we ask our experts to share their in-depth expertise on topics within the pharmaceutical industry. In this instalment, we asked ou
March 9, 2020

Industry Insights ... Scientific Records

Preservation of Scientific Records The acquisition and analysis of experimental data is the foundation of all scientific research, including pharmaceuticals. However, it d
November 17, 2019

Industry Insights with… Sheila Lawson

Welcome to the latest blog in our Industry Insights series, where we ask our experts to share their in-depth expertise on topics within the pharmaceutical industry. We recently asked our Chemistry
April 27, 2019

Industry Insights with… Paul Quigley

To coincide with CPhI North America 2019, we asked our Head of Drug Substance, Paul Quigley, to share his thoughts on the changing CDMO sector. The latest blog in our Industry Insights series high